Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial

Somsen, Y. B. O., de Winter, R. W., Wu, J., Hoek, R., Sprengers, R. W., Verouden, N. J., Claessen, B. E. P. M., Kleijn, S. A., Twisk, J. W. R., Henriques, J. P., Spratt, J. C., Rissanen, T. T., McEntegart, M. B., Maehara, A., Nap, A., & Knaapen, P. (2025). Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial. American Heart Journal. https://doi.org/10.1016/j.ahj.2025.03.023
Authors:
Yvemarie B O Somsen
Ruben W de Winter
Jiawei Wu
Roel Hoek
Ralf W Sprengers
Niels J Verouden
Bimmer E P M Claessen
Sebastiaan A Kleijn
Jos W R Twisk
José P Henriques
James C Spratt
Tuomas T Rissanen
Margaret B McEntegart
Akiko Maehara
Alexander Nap
Paul Knaapen
Affiliated Authors:
Jiawei Wu
Margaret B McEntegart
Akiko Maehara
Author Keywords:
chronic total coronary occlusion
coronary artery disease
drug-coated balloon
percutaneous coronary intervention
randomized controlled trial
trial design
Publication Type:
Article
Unique ID:
10.1016/j.ahj.2025.03.023
PMID:
Publication Date:
Data Source:
PubMed

Record Created: